NewslettersImmune Regulation NewsQuoin Pharmaceuticals Announces Plans to Initiate a Second Clinical Trial in Netherton Syndrome PatientsBy Bob - October 21, 20220234Quoin Pharmaceuticals Ltd. announced that it has begun initiating a second clinical trial in Netherton Syndrome patients.[Quoin Pharmaceuticals Ltd.]Press Release